FDA Caves in on Olestra

Statement of CSPI Executive Director Michael F. Jacobson
Today's FDA action on olestra is a mistake that will inflict
needless misery, inconvenience, and embarrassment for
countless Americans. Procter & Gamble's own studies
prove olestra causes diarrhea, cramps, and other symptoms.
If that weren't enough, the FDA has more than 20,000
complaints about olestra in its files--more than it has
for all other food additives in history combined.
Fortunately, since consumers don't seem to like the taste,
texture, or side-effects of olestra, the marketshare for
olestra-containing chips has diminished. But without an
adequate warning label, olestra-containing chips may
inadvertently find their way into shopping carts and
lunchboxes of even those consumers who are trying to
avoid olestra.
This is just another in a string of setbacks for the
public's health, engineered by an FDA that seems all too
eager to do the bidding of big food companies.
 |